Abstract
In the course of screening for an inhibitor of ER stress-induced XBP1 activation, we isolated a new member of the triene-ansamycin group compound, trierixin, from a culture broth of Streptomyces sp. AC 654. Trierixin was purified by column chromatography on silica gel and by HPLC. The molecular formula of trierixin is C37H52N2O8S. Trierixin inhibited thapsigargin-induced XBP1-luciferase activation in HeLa/XBP1-luc cells and endogenous XBP1 splicing in HeLa cells with an IC 50 of 14 ng/ml and 19 ng/ml, respectively. Moreover, in the process of isolating trierixin, we isolated structurally related mycotrienin II and trienomycin A as inhibitors of ER stress-induced XBP1 activation from a culture broth of a trierixin-producing strain. This study provides the first observation that triene-ansamycins have a novel inhibitory effect against XBP1 activation.
Original language | English |
---|---|
Pages (from-to) | 547-553 |
Number of pages | 7 |
Journal | Journal of Antibiotics |
Volume | 60 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2007 Sept |
Externally published | Yes |
Keywords
- ER stress
- Triene-ansamycin
- Trierixin
- XBP1
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery